Other Clients/Companies To Watch:

Access Pharmaceuticals, Inc
(OTC: ACCP)

Aedeona
(AMEX:AEN)

Alexza Pharmaceuticals, Inc.
(NASDAQ:ALXA)

Cardiogenics Holdings, Inc.
(OTC:CGNH)

Crucell N.V.
(Euronext, NASDAQ: CRXL)

Digital Angel Corporation
(AMEX:DOC)

Dynavax Technologies Corporation
(NASDAQ:DVAX)

Elan Corporation
(NYSE: ELN)

Galapagos NV
(Euronext:GLPGA)

KERYX Biopharmaceuticals, Inc.
(NASDAQ:KERX)

Lpath, Inc.
(OTC:LPTN)

Manhattan Pharmaceuticals, Inc.
(AMEX:MHA)

Mediware Information Systems, Inc. (NASDAQ: MEDW)

Redpoint Bio Corporation
(OTC:RPBC)

VIA Pharmaceuticals, Inc.
(NASDAQ: VIAP)

ZIOPHARM, INC.
(NASDAQ:ZIOP)

Through its operating subsidiaries, the Company develops its Point-Of-Care analyzer and products targeting the immunoassay segment of the IVD market. It has developed the QL Care™ Analyzer, a proprietary and ultra-sensitive Point-Of-Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating magnetic beads (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

AT A GLANCE | COMPANY NEWS | COMPANY WEBSITE |SEC FILINGS